FOLH1 and cancer: Prostate Specific Membrane Antigen (PSMA) based imaging is the preferred modality to assess patients for cancer recurrence or persistence following radical prostatectomy due to its high sensitivity compared to traditional imaging modalities such as multiparametric MRI and CT (28).